A Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphoma
Conference
Bernengo, MG, Vanaclocha, F, Duvic, M et al. (2008). A Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphoma
. 2(5), 44-45.
Bernengo, MG, Vanaclocha, F, Duvic, M et al. (2008). A Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphoma
. 2(5), 44-45.